Navigation Links
IMA Accuses US Companies for Selling Recycled Prosthesis in India

The Indian Medical Association (IMA) has accused US multi-national companies of selling recycled prosthesis in India at cheaper prices .

"It is shocking but true that US companies are selling recycled prosthesis in India," IMA president Ajay Kumar said here.

Kumar alleged that US companies are selling knee and hip prosthesis at $4,000 each in India but in US it is sold for $6000. "The secret of cheaper prices in India is that the US companies are selling recycled ones here," Kumar told IANS.

According to him, the cost of manufacturing prosthesis in US is around $5,000. "How can the US companies sell them for less?" he asked.

The US companies use the word "reprocessed" instead of "recycled" to sell them in India. He said after an outcry in the US against selling recycled prosthesis there, the companies turned to India and other Asian countries.

"After protests and lawsuits were filed against the companies they stopped selling them in the US," he said.

Comparing the recycled prosthesis with used toothbrush, Kumar said: "It may or may not be harmful but its life is half of that of a new prosthesis."


'"/>




Page: 1

Related medicine news :

1. Cherie Blairs Boss Accuses Tony Blair for Proposed Smoking Ban
2. Ex-CIA Official Accuses Retired ISI Chief of Supporting Taliban
3. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
4. Pharma Companies May Influence The Decisions Of Medical Students
5. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
6. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
7. Doctors, Pharma Companies Targeted By CBI Raids
8. Raids Conducted In Hospitals And Pharmaceutical Companies
9. Australia to Show Leniency towards U.S. Pharmaceutical Companies
10. Pharma Companies Tie Up To Develop Bird Flu Vaccine
11. Companies Not Doing Enough To Fight Bird Flu
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology: